Pemetrexed Disodium in Treating Patients With Previously Treated Metastatic Urothelial Cancer
Status:
Terminated
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well pemetrexed disodium works in treating patients with
previously treated urothelial cancer that has spread from the primary site (place where it
started) to other places in the body. Pemetrexed disodium may stop the growth of tumor cells
by blocking some of the enzymes needed for cell growth.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborators:
Eli Lilly and Company National Cancer Institute (NCI)